Journal of Diabetes Research

Research Article

Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection

Table 1

Baseline characteristic of the whole population.
VariablesWhole population ()
Age (years)67.3 ± 11.4
Sex (male)80.7%
Diabetes (type 2)95.1%
Diabetes duration (years)
HbA1c (mmol/mol) (%) ()
Hypertension (yes)73.1%
Dyslipidemia (yes)72.1%
Current smokers11.1%
IHD72.8%
Heart failure27.9%
CAD15.8%
ESRD (dialysis)37.2%
Procalcitonin (ng/ml)
ESR (mm/h)
CRP (mg/dl)
WBC (×103/ml)
Fibrinogen (mg/ml)
Wound parameters
Dimension (>5 cm2)83.1%
TcPO2 basal (mmHg)
IHD: Ischemic heart disease; CAD: carotid artery disease; ESRD: end-stage renal disease; ESR: erythrocyte sedimentation rate; CRP: c-reactive protein; TcPO2: transcutaneous foot oximetry; WBC: white blood cells; PTA: percutaneous transluminal angioplasty.